VAR - Varian Medical Systems, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5 12.31B
Enterprise Value 3 11.72B
Trailing P/E 32.89
Forward P/E 1 25.25
PEG Ratio (5 yr expected) 1 4.25
Price/Sales (ttm) 4.06
Price/Book (mrq) 7.11
Enterprise Value/Revenue 3 3.87
Enterprise Value/EBITDA 6 21.18

Trading Information

Stock Price History

Beta (3Y Monthly) 0.94
52-Week Change 3 15.84%
S&P500 52-Week Change 3 6.52%
52 Week High 3 142.50
52 Week Low 3 0.00
50-Day Moving Average 3 133.43
200-Day Moving Average 3 132.75

Share Statistics

Avg Vol (3 month) 3 546.86k
Avg Vol (10 day) 3 540.52k
Shares Outstanding 5 90.95M
Float 90.69M
% Held by Insiders 1 0.26%
% Held by Institutions 1 95.14%
Shares Short (Jun 28, 2019) 4 1.56M
Short Ratio (Jun 28, 2019) 4 3.49
Short % of Float (Jun 28, 2019) 4 1.92%
Short % of Shares Outstanding (Jun 28, 2019) 4 1.72%
Shares Short (prior month May 31, 2019) 4 1.65M

Dividends & Splits

Forward Annual Dividend Rate 4 N/A
Forward Annual Dividend Yield 4 N/A
Trailing Annual Dividend Rate 3 N/A
Trailing Annual Dividend Yield 3 N/A
5 Year Average Dividend Yield 4 N/A
Payout Ratio 4 0.00%
Dividend Date 3 N/A
Ex-Dividend Date 4 Dec 2, 1998
Last Split Factor (new per old) 2 8769/10000
Last Split Date 3 Jan 30, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 28, 2018
Most Recent Quarter (mrq) Mar 29, 2019

Profitability

Profit Margin 12.56%
Operating Margin (ttm) 15.82%

Management Effectiveness

Return on Assets (ttm) 8.95%
Return on Equity (ttm) 23.87%

Income Statement

Revenue (ttm) 3.03B
Revenue Per Share (ttm) 33.24
Quarterly Revenue Growth (yoy) 6.80%
Gross Profit (ttm) 1.27B
EBITDA 553.5M
Net Income Avi to Common (ttm) 380.8M
Diluted EPS (ttm) 4.12
Quarterly Earnings Growth (yoy) 21.00%

Balance Sheet

Total Cash (mrq) 546.3M
Total Cash Per Share (mrq) 6.01
Total Debt (mrq) N/A
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 1.72
Book Value Per Share (mrq) 19.03

Cash Flow Statement

Operating Cash Flow (ttm) 337.9M
Levered Free Cash Flow (ttm) 267.05M